Bifidobacterium animalis ssp. lactis 420 Protects against Indomethacin-Induced Gastric Permeability in Rats

Table 3

Urinary sucrose levels of rats grouped according to lesion status.

Group^a	Lesion status	N	Urinary sucrose levels
			Mean (mg/sample)	SD
Control	No lesions	35	16.35	6.72
	Lesions	5	18.86	11.23
	All	40	16.66	7.28
NSAID	No lesions	8	31.56	10.24
	Lesions	32	21.57	9.21
	All	40	23.57	10.13
Probiotic	No lesions	9	17.42	7.64
	Lesions	30	17.45	8.41
	All	39	17.45	8.14

^aThe treatment groups were control, indomethacin-challenged group (NSAID), and a probiotic group supplemented daily with 10¹⁰ colony forming units of Bifidobacterium lactis 420 for seven days prior to indomethacin challenge.